Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a new build deployment of the page.SummaryDifference0.0%

- Check19 days agoChange DetectedA new note indicating NIH funding in 2018 was added to the study's identifiers. This adds funding context to the trial but does not change its design, population, or outcomes.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the site's code or templates rather than a change to study information.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a maintenance release to the ClinicalTrials.gov entry. The study details appear unchanged in this update.SummaryDifference0.0%

- Check76 days agoChange DetectedThe revision tag has changed from v3.6.0 to v3.6.3, indicating a version bump for the page or its underlying components. This update appears to be an internal version increment rather than a visible content change.SummaryDifference0.0%

- Check90 days agoChange DetectedAdds an explicit recruitment notice 'No longer looking for participants' and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). The revision tag updates from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.